| pubmed-article:17431344 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17431344 | lifeskim:mentions | umls-concept:C0235032 | lld:lifeskim |
| pubmed-article:17431344 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:17431344 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:17431344 | lifeskim:mentions | umls-concept:C0360641 | lld:lifeskim |
| pubmed-article:17431344 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17431344 | pubmed:dateCreated | 2007-4-13 | lld:pubmed |
| pubmed-article:17431344 | pubmed:abstractText | Oxaliplatin in combination with infusional 5-fluorouracil/leucovorin (FOLFOX) have emerged as the standard of care in the therapy of advanced-stage colorectal cancer. Sensory neurotoxicity is its dose-limiting toxicity. We decided to use Ca and Mg for prevention of oxaliplatin-related neurotoxicity with reference to the report of Gamelin et al. | lld:pubmed |
| pubmed-article:17431344 | pubmed:language | jpn | lld:pubmed |
| pubmed-article:17431344 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17431344 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17431344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17431344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17431344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17431344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17431344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17431344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17431344 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17431344 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17431344 | pubmed:issn | 0385-0684 | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:KobayashiYosh... | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:OnoTakashiT | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:AndoHideakiH | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:TanakaYuichiY | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:MutoOsamuO | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:AkashiTatsuru... | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:ItagakiHiroko... | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:HanaokaTakaoT | lld:pubmed |
| pubmed-article:17431344 | pubmed:author | pubmed-author:OnukiManabuM | lld:pubmed |
| pubmed-article:17431344 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17431344 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:17431344 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17431344 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17431344 | pubmed:pagination | 579-81 | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:meshHeading | pubmed-meshheading:17431344... | lld:pubmed |
| pubmed-article:17431344 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17431344 | pubmed:articleTitle | [Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions]. | lld:pubmed |
| pubmed-article:17431344 | pubmed:affiliation | Division of Surgery, Nakadori General Hospital. | lld:pubmed |
| pubmed-article:17431344 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17431344 | pubmed:publicationType | English Abstract | lld:pubmed |
